Table 1.
Properties of polymeric nanoparticles
| PNP formulation | PNPs characteristics | ||||
|---|---|---|---|---|---|
| Average size (nm) | PDI | Zeta potential (mV) | Drug/Dye concentration | Dry matter amount (mg/ml) | |
| Cis-Pt@PNPs | 90.3 ± 0.3 | 0.254 | -21.4 | 460.78 µM (0.138 µg/µl) | 7 |
| Cis-Pt@PNPs-CL4 | 91.1 ± 1.4 | 0.290 | -12.2 | 422.70 µM (0.127 µg/µl) | 7 |
| Cis-Pt@PNPs-SCR | 118.5 ± 20 | 0.290 | -11.1 | 455.18 µM (0.136 µg/µl) | 7 |
| BODIPY@PNPs | 97.6 ± 0.3 | 0.142 | 0.08 | 166 µM | 8 |
| BODIPY@PNPs-CL4 | 131.9 ± 0.2 | 0.185 | -17.9 | 13.6 µM | 5 |
| BODIPY@PNPs-SCR | 142.2 ± 1.5 | 0.185 | -23.4 | 9.7 µM | 5 |
| Cy7@PNPs | 90.5 ± 0.5 | 0.218 | -24.9 | 104.16 µM | 4 |
| Cy7@PNPs-CL4 | 107.9 ± 0.3 | 0.350 | -20.6 | 106.8 µM | 6 |
| Cy7@PNPs-SCR | 104.2 ± 2.7 | 0.350 | -20.6 | 105.96 µM | 6 |